Today: 19 May 2026
Qualcomm stock price drops 11% premarket after weak forecast flags memory crunch
5 February 2026
2 mins read

Qualcomm stock price drops 11% premarket after weak forecast flags memory crunch

NEW YORK, February 5, 2026, 04:45 EST — Premarket

  • Qualcomm shares dropped roughly 11% in premarket trading following a weaker-than-expected forecast for the March quarter.
  • Management linked the outlook to memory supply bottlenecks and rising prices weighing on handset production, particularly in China.
  • Investors want to see if the bottleneck clears ahead of the next earnings update on May 6.

Qualcomm Incorporated (QCOM.O) shares dropped 11.1% to $132.34 in premarket trading Thursday, following a forecast that missed revenue and earnings estimates amid a global memory-chip shortage. The stock had closed Wednesday at $148.89.

The outlook is hitting a market already on edge over consumer electronics demand. Qualcomm, a major supplier for premium smartphones, often sets the tone with its guidance, giving a quick snapshot of what phone makers can realistically produce and ship soon.

On the earnings call, CEO Cristiano Amon warned that memory shortages and price hikes could “define” the handset industry’s scale throughout the fiscal year. He noted memory suppliers are shifting capacity to high-bandwidth memory for AI data centers, squeezing supply available for phones. Investing.com Australia

Qualcomm projected fiscal second-quarter revenue between $10.2 billion and $11.0 billion, with non-GAAP diluted EPS expected to fall in the $2.45 to $2.65 range. This non-GAAP figure excludes items like stock-based compensation. The company noted that its forecast factors in the anticipated impact of memory supply shortages affecting demand from several handset customers.

CFO Akash Palkhiwala noted that handset customers are cautious about building plans and managing channel inventory amid shifting memory supply and pricing. “Demand fundamentals are strong, and really, it’s a question of how supply aligns against it,” he said. Investing.com Australia

Qualcomm posted revenue of $12.25 billion for the fiscal first quarter ended Dec. 28, marking a 5% rise year-over-year. Non-GAAP diluted EPS came in at $3.50. “We are pleased to deliver strong quarterly results, with record total company revenues,” Amon said in the earnings release. s204.q4cdn.com

The core chip division, QCT, reported $10.61 billion in revenue, with the licensing segment QTL bringing in $1.59 billion. Inside QCT, handset sales hit $7.82 billion, automotive revenue jumped 15% to $1.10 billion, and IoT climbed 9% to $1.69 billion.

Qualcomm returned $3.6 billion to shareholders this quarter, handing out $949 million in dividends and spending $2.6 billion on buybacks. The company repurchased 15 million shares, according to its earnings release.

For the current quarter, Palkhiwala expects QCT handset revenue to hit around $6 billion, citing the memory supply issue he mentioned earlier. Qualcomm’s overall QCT revenue guidance ranges from $8.8 billion to $9.4 billion.

Qualcomm is pushing beyond just phones, focusing more on autos, PCs, and data centers. The company announced it has closed its acquisition of Alphawave Semi, presenting it as a key move in its data-center strategy.

In the smartphone supply chain, Arm flagged memory shortages as a drag on mobile processor sales, highlighting that the bottleneck extends beyond just one player. A TECHnalysis Research analyst noted Qualcomm—and other device-chip makers—are expected to grapple with the memory squeeze for multiple quarters.

The risk is clear: if memory supply tightens more, phone manufacturers might scale back production once again, putting Qualcomm’s handset recovery at risk. This scenario would also challenge whether gains in automotive and emerging segments can compensate for a prolonged slump in phones.

With the overnight drop setting the stage, traders are turning to the U.S. open for clearer signals on liquidity and positioning. Qualcomm is set to report earnings on May 6, a key date investors will watch closely for clues on whether memory supply and pricing have steadied and if handset orders in China are picking up.

Stock Market Today

  • When Will Island Pharmaceuticals Limited (ASX:ILA) Reach Profitability?
    May 19, 2026, 3:26 AM EDT. Island Pharmaceuticals Limited (ASX:ILA), a drug repurposing company focusing on antiviral therapeutics in Australia and the U.S., posted a AU$3.9 million loss in the latest financial year and a AU$7.2 million loss over the trailing twelve months. Analysts project the company will break even in 2027 and reach a profit of AU$295 million by 2028. This forecast implies an ambitious average annual growth rate of 140%. Notably, Island Pharmaceuticals operates with no debt, relying solely on shareholder funding, which reduces financial risk typical in cash-burning pharmaceutical firms. Investors anticipate milestone developments but should remain cautious of the high growth assumptions given the volatile nature of pharmaceutical cash flows during drug development phases.

Latest articles

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

19 May 2026
Dominion Energy shares jumped 9.4% after agreeing to an all-stock merger with NextEra Energy, whose shares fell 4.6%. The S&P 500 slipped 0.1% and the Nasdaq dropped 0.5% as investors sold technology stocks amid rising Treasury yields and oil prices. Nvidia fell 1.4% ahead of earnings. U.S. crude settled at $107.37, and the 10-year Treasury yield reached 4.59%.
XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

19 May 2026
XP Inc.’s U.S.-listed shares fell 3.78% in after-hours trading Monday after reporting higher Q1 profit but weaker net inflows and a lower retail take rate. Net income rose 7% to 1.32 billion reais, but net inflow dropped to 14 billion reais from 24 billion a year earlier. The company declared a $0.20 dividend and announced a new CFO, Gustavo Alejo Viviani, starting August 3.
LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

19 May 2026
Publicis Groupe agreed to buy LiveRamp Holdings for $38.50 a share in cash, valuing the U.S. data-collaboration firm at $2.546 billion. LiveRamp stock jumped to $37.77 on the news, while the broader market fell. LiveRamp reported fiscal Q4 revenue of $206 million, up 9% from a year earlier. Publicis said the deal will boost its adjusted earnings per share from the first year after closing.

Popular

ServiceNow Jumps After Wall Street Shifts AI View

ServiceNow Jumps After Wall Street Shifts AI View

19 May 2026
ServiceNow shares surged 8.8% to $103.42 Monday after Bank of America reinstated coverage with a Buy rating and $130 target. Volume hit 50.74 million shares, nearly double the average. The move contrasted with a broader tech selloff as the Nasdaq fell 0.51%. ServiceNow remains down about a third this year despite strong Q1 subscription revenue and raised guidance.
Anglo American share price slips after copper output drop, 2026 guidance cut
Previous Story

Anglo American share price slips after copper output drop, 2026 guidance cut

Volvo Car AB stock sinks 22% as Q4 profit slumps and tariffs bite
Next Story

Volvo Car AB stock sinks 22% as Q4 profit slumps and tariffs bite

Go toTop